In experimental studies, CNP has demonstrated the ability to suppress cardiac fibroblast proliferation, collagen synthesis, and myocardial fibrosis, therefore it could be inferred that in AF, CNP could be elevated as a compensatory mechanism to reverse myocardial fibrogenesis seen in AF[53]. The gene discussed is CNP; the disease is atrial fibrillation.